Effects of S-salbutamol on human isolated bronchus

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1998, Pages 1-6

  Templeton, A G B ^a   Chapman, I D ^a   Chilvers, E R ^b   Morley, J ^a,d   Handley, D A ^c  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SUNOVION PHARMACEUTICALS INC   (United States)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Airway hyperreactivity; Histamine; Human bronchus; Peptidoleukotriene C4; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; CAPSAICIN; HISTAMINE; LEUKOTRIENE C4; METHACHOLINE; SALBUTAMOL; SPASMOGEN;

AIRWAY CONSTRICTION; ALLERGIC DISEASE; ARTICLE; BRONCHODILATATION; BRONCHOSPASM; BRONCHUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RACEMIC MIXTURE;

EID: 0032004071     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1998.0110     Document Type: Review

References (23)

1. 2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol and combinations thereof). A study with salbutamol and asthmatics. Am Rev Respir Dis 1977; 116: 861-869.
2. 2. Britton J, Hanley S P, Garnett H V, Hadfield J W, Tattersfield A E. Dose-related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988; 43: 300-305.
3. 3. Jenne J W, Ahrens R C. Pharmacokinetics of β-adrenergic compounds. In: Jenn J W, Murphy S eds. Drug therapy for asthma: research and clinical practice. New York: Marcel Dekker, 1987: 213-258.
4. 4. Ahrens R C, Harris J B, Milavetz G, Annis L, Ries R. Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma. J Allergy Clin Immunol 1987; 79: 876-882.
5. 2 agonists. Thorax 1996; 51: 1051-1056.
6. 6. Morley J. Anomalous effects of albuterol and other sympathomimetics in the guinea pig. Clin Revs Allergy Immunol 1996; 14: 65-89.
7. 7. Sanjar S, Morley J. Airway hyperreactivity. Lancet 1988; 2: 160-161.
8. 8. Sanjar S, Kristersson A, Mazzoni L, Morley J, Schaeublin E. Increased airway reactivity in the guinea pig follows exposure to intravenous isoprenaline. J Physiol 1990; 425: 43-54.
9. 2-selective sympathomimetics. Pulm Pharmacol 1994; 7: 367-376.
10. 10. Johansson F, Rydberg I, Aberg G, Andersson R G G. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Revs Allergy Immunol 1996; 14: 57-64.
11. 11. Hoshiko K, Morley J. Exacerbation of airway hyperreactivity by racemic salbutamol in sensitized guinea-pigs. Jpn J Pharmacol 1993; 63: 159-163.
12. 12. Andersson R G G, Aberg G, Handley D A, Morley J. Effects of S-salbutamol on airway smooth muscle. Eur Resp Rev 1996; 9: S133.
13. 13. Brittain R T, Farmer J B, Marshall R J. Some observations of the β-adrenoceptor agonist properties of the isomers of salbutamol. Br J Pharmacol 1973; 48: 144-147.
14. 14. Dahlen S E, Hedqvist P, Hammarstrom S. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288: 484-486.
15. 15. Butchers B R, Fullerton J R, Skidmore I F, Thomson L E, Vardey C J, Wheeldon A. A comparison of the anti-anaphylactic activities of salbutamol and disodium-cromoglycate in the rat, the rat mast cell and in human lung tissue. Br J Pharmacol 1974; 67: 23-32.
16. 16. Goldie R G, Spina D, Henry P J, Lulich K M, Paterson J W. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, β-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 1986; 22: 669-676.
17. 4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle in vitro. Br J Pharmacol 1991; 104: 859-866.
18. 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995; 152: 1485-1489.
19. 19. Bhagat R, Swystun V A, Cockcroft D W. Salbutamol-induced increased airway responsiveness to allergen and reduced protection vs. methacholine dose response. J Allergy Clin Immunol 1996; 97: 47-52.
20. 2-agonist treatment. Am Rev Respir Dis 1993; 148: 707-712.
21. 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive disease. Thorax 1991; 46: 9-14.
22. 22. Crowther S D, Chapman I D, Morley J. Heterogeneity of airway hyperreactivity. Clin Allergy Immunol 1997; 27: 606-616.
23. 23. Handley D A, McCullough J, Crowther S D, Morley J. Sympathomimetic enantiomers and asthma therapy. Chirality 10: 262-272.